Digital Resistance Training for Midlife Women Using GLP-1

(PLAN-RT Trial)

SL
KA
Overseen ByKimberly Allen
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Louisiana State University and A&M College
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of PLAN-RT 1.0 to learn if a 12-week app-based strength training program can help midlife women build and stick with a regular strength training routine while they are taking GLP-1 medication for weight loss. PLAN-RT 1.0 targets women ages 40 to 59 who were not regularly exercising before starting GLP-1 medication.

The main questions this study aims to answer are: (1) Is the PLAN-RT 1.0 program feasible and acceptable to participants (based on how many people join, stay in the study, and use the program)? (2) Does the program lead to early changes in muscle strength, body composition, physical function, and exercise habits?

Are You a Good Fit for This Trial?

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: PLAN-RT 1.0Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Louisiana State University and A&M College

Lead Sponsor

Trials
12
Recruited
1,100+

Louisiana Clinical and Translational Science Center

Collaborator

Trials
3
Recruited
180+

Pennington Biomedical Research Center

Collaborator

Trials
314
Recruited
183,000+